NDC properties for "Thalomid 150 MG Oral Capsule" (RxCUI 700418)
About this data
The tables show NDC propoerties for Thalomid 150 MG Oral Capsule with the RxCUI 700418
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Thalomid 150 MG Oral Capsule (RxCUI 700418)
| MMSL_CODE | BD22658 |
|---|---|
| NDA | NDA020785 |
| RxCUI | 700418 |
| SPL_SET_ID | 2eda833b-1357-4ed4-a093-194524fcb061 |
| Prescribable Synonym | Thalomid 150 MG Oral Capsule |
| RXNAV_STR | Thalomid 150 MG Oral Capsule |
| RxNorm Name | thalidomide 150 MG Oral Capsule [Thalomid] |
| RxNorm Synonym | Thalomid 150 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 700418) |
NDC Properties
NDC Item 59572021513
| NDC 9 | 59572-215 |
|---|---|
| NDC 10 | 59572-215-13 |
| NDC Item | 59572021513 |
| Packaging | 28 in 1 BLISTER PACK |
| COLORTEXT | BLUE,BROWN |
| Color | C48333;C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;150;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-03-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 59572-215 |
NDC Item 59572021593
| NDC 9 | 59572-215 |
|---|---|
| NDC 10 | 59572-215-93 |
| NDC Item | 59572021593 |
| Packaging | 4 BLISTER PACK in 1 BOX (59572-215-93) / 28 CAPSULE in 1 BLISTER PACK (59572-215-13) |
| COLORTEXT | BLUE,BROWN |
| Color | C48333;C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;150;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-03-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 59572-215 |
NDC Item 59572021513
| NDC 9 | 59572-215 |
|---|---|
| NDC 10 | 59572-215-13 |
| NDC Item | 59572021513 |
| Packaging | 28 in 1 BLISTER PACK |
| COLORTEXT | BLUE,BROWN |
| Color | C48333;C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;150;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-03-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 59572-215 |
NDC Item 59572021593
| NDC 9 | 59572-215 |
|---|---|
| NDC 10 | 59572-215-93 |
| NDC Item | 59572021593 |
| Packaging | 4 BLISTER PACK in 1 BOX (59572-215-93) / 28 CAPSULE in 1 BLISTER PACK (59572-215-13) |
| COLORTEXT | BLUE,BROWN |
| Color | C48333;C48332 __ |
| FDA SPL set id | 704313 |
| Imprint code | Celgene;150;mg;Do;Not;Get;Pregnant;Symbol |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-03-20 |
| Marketing status | ACTIVE |
| NDA | NDA020785 |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 59572-215 |